Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications
Ming Zhu(AbbVie (United States)), Xiang Xu(Yanbian University), Li Zhan(Army Medical University), Wei Guo(Army Medical University), Luoquan Ao(Army Medical University), Wei Qiu(Loyola University Chicago), Nan Xiao(Central South University), Xiao He(Daping Hospital), Jian Yu(University of Southern California), Xiaoping Liu(Qingdao University), Xueting Hu(Beihang University), Wei Xing(Sun Yat-sen University), Hong Huang(Army Medical University), Xiaohui Wang(Dalian Maternal and Child Health Hospital), Tianchen An(Army Medical University)
Cited by 25
Related Papers
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Analysis of human transcriptomes
|Nature Genetics|1999|789
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
|Journal of Clinical Oncology|2017|752
METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer
|Molecular Cancer|2022|498
Meningeal lymphatic vessels regulate brain tumor drainage and immunity
|Cell Research|2020|376